Research progress on the anti-hepatic fibrosis action and mechanism of natural products
Abstract
Hepatic fibrosis is the most common pathological feature of most chronic liver diseases, and its continuous deterioration gradually develops into liver cirrhosis and eventually leads to liver cancer. At present, there are many kinds of drugs used to treat liver fibrosis. However, Western drugs tend to only target single genes/proteins and induce many adverse reactions. Most of the mechanisms and active ingredients of traditional Chinese medicine (TCM) are not clear, and there is a lack of unified diagnosis and treatment standards. Natural products, which are characterized by structural diversity, low toxicity, and origination from a wide range of sources, have unique advantages and great potential in anti-liver fibrosis. This article summarizes the work done over the previous decade, on the active ingredients in natural products that are reported to have anti-hepatic fibrosis effects. The effective anti-hepatic fibrosis ingredients identified can be generally divided into flavonoids, saponins, polysaccharides and alkaloids. Mechanisms of anti-liver fibrosis include inhibition of liver inflammation, anti-lipid peroxidation injury, inhibition of the activation and proliferation of hepatic stellate cells (HSCs), modulation of the synthesis and secretion of pro-fibrosis factors, and regulation of the synthesis and degradation of the extracellular matrix (ECM). This review provides suggestions for the development of anti-hepatic fibrosis drugs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In advanced liver fibrosis, macrophages maintain the inflammatory environment and accelerate liver fibrosis deterioration by secreting proinflammatory cytokines.
“In advanced liver fibrosis (LF), macrophages maintain the inflammatory environment in the liver and accelerate LF deterioration by secreting proinflammatory cytokines.”
From An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis (2024) · cites this paper as [11]
Macrophages, especially bone marrow macrophages recruited to the liver during inflammation, play a central role in secretion of inflammatory cytokines.
“Macrophages, especially bone marrow macrophages that are recruited to the liver during inflammation, act a central role in the secretion of inflammatory cytokines.[ 11 ]”
From An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis (2024) · cites this paper as [11]
Cites
1 retracted
Yu, F., Lu, Z., Chen, B., Wu, X., Dong, P., & Zheng, J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12655 · Cited by 91 · see citing works
RetractedAlcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963 · see citing works
The global burden of liver disease: The major impact of China
Wang, F., Fan, J., Zhang, Z., Gao, B., & Wang, H. (2014) · Hepatology · doi:10.1002/hep.27406 · Cited by 1,258 · see citing works
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,226 · see citing works
TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Xu, F., Liu, C., Zhou, D., & Zhang, L. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155415627681 · Cited by 759 · see citing works
Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression
Ramirez, T., Li, Y.-M., Yin, S., Xu, M.-J., Feng, D., Zhou, Z., Zang, M., Mukhopadhyay, P., Varga, Z. V., Pacher, P., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.004 · Cited by 186 · see citing works
Wang, R., Zhang, H., Wang, Y., Song, F., & Yuan, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.03.029 · Cited by 145 · see citing works
Pascoli, M. D., Diví, M., Rodrı́guez-Vilarrupla, A., Rosado, E., Gracia‐Sancho, J., Vilaseca, M., Bosch, J., & García‐Pagán, J. C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.012 · Cited by 136 · see citing works
Mathews, S., Xu, M., Wang, H., Bertola, A., & Gao, B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2014 · Cited by 127 · see citing works
Li, J., Li, X., Xu, W., Wang, S., Hu, Z., Zhang, Q., Deng, X., Wang, J., Zhang, J., & Guo, C. (2014) · Liver International · doi:10.1111/liv.12638 · Cited by 126 · see citing works
Self-citationWu, Y., Liu, X., Zhou, Q. Y., Huang, C., Meng, X., Xu, F., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.09.028 · Cited by 116 · see citing works
Self-citationGan, F., Liu, Q., Liu, Y., Huang, D. W., Pan, C., Song, S., & Huang, K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.047 · Cited by 113 · see citing works
Li, R., Xu, L., Liang, T., Li, Y., Zhang, S., & Duan, X. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.059 · Cited by 111 · see citing works
Effects of garlic polysaccharide on alcoholic liver fibrosis and intestinal microflora in mice
Wang, Y., Guan, M., Zhao, X., & Li, X. (2018) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1479868 · Cited by 110 · see citing works
Yang, F., Luo, L., Zhu, Z., Zhou, X., Wang, Y., Xue, J., Zhang, J., Cai, X., Chen, Z.-L., Ma, Q., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00929 · Cited by 107 · see citing works
Yan, F., Zhang, Q., Jiao, L., Han, T., Zhang, H., Qin, L., & Khalid, R. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.02.004 · Cited by 106 · see citing works
Liu, Y., Wen, P., Zhang, X., Dai, Y., & He, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3651 · Cited by 102 · see citing works
Wang, Q., Dai, X., Yang, W., Wang, H., Zhao, H., Yang, F., Yang, Y., Li, J., & Lv, X. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.012 · Cited by 95 · see citing works
Self-citationYu, H., Yao, Y., Bu, F., Chen, Y., Wu, Y., Yang, Y., Chen, X., Zhu, Y., Wang, Q., Pan, X., et al. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.01.004 · Cited by 92 · see citing works
Self-citationHotair facilitates hepatic stellate cells activation and fibrogenesis in the liver
Bian, E., Wang, Y., Yang, Y., Wu, B., Xu, T., Meng, X., Huang, C. Z., Zhang, L., Lv, X., Xiong, Z., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.009 · Cited by 90 · see citing works
Self-citationNaringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
Hernández‐Aquino, E., Zarco, N., Casas‐Grajales, S., Ramos‐Tovar, E., Flores‐Beltrán, R. E., Arauz, J., Shibayama, M., Favari, L., Tsutsumi, V., Segovia, J., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i24.4354 · Cited by 87 · see citing works
Effect of Fuzheng Huayu formula and its actions against liver fibrosis
Liu, C., Hu, Y., Xu, L., Liu, C., & Liu, P. (2009) · Chinese Medicine · doi:10.1186/1749-8546-4-12 · Cited by 82 · see citing works
Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis
Hsu, Y., Chiu, Y., Cheng, C., Wu, C., Lin, Y., & Huang, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04361.x · Cited by 82 · see citing works
Wang, X., Ikejima, K., Kon, K., Arai, K., Aoyama, T., Okumura, K., Abe, W., Sato, N., & Watanabe, S. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.040 · Cited by 82 · see citing works
Lai, L., Chen, Y., Tian, X., Li, X., Zhang, X., Lei, J., Bi, Y., Fang, B., & Song, X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.040 · Cited by 80 · see citing works
Chen, W., Zhang, Z., Yao, Z., Wang, L., Zhang, F., Shao, J., Chen, A., & Zheng, S. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.029 · Cited by 80 · see citing works
Choi, J. H., Jin, S. W., Choi, C. Y., Kim, H. G., Lee, G. H., Kim, Y.-A., Chung, Y., & Jeong, H. G. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b04805 · Cited by 77 · see citing works
Baltă, C., Herman, H., Boldura, O. M., Gasca, I., Roșu, M., Ardelean, A., & Hermenean, A. O. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.08.013 · Cited by 76 · see citing works
Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis
Wang, J., Li, L., Li, L., Qi, Y., Li, J., & Xu, T. (2018) · Gene · doi:10.1016/j.gene.2018.06.053 · Cited by 76 · see citing works
Self-citationNovel Insights on Notch signaling pathways in liver fibrosis
Ni, M.-M., Wang, Y.-R., Wu, W., Xia, C.-C., Zhang, Y.-H., Xu, J., Xu, T., & Li, J. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.02.051 · Cited by 73 · see citing works
Self-citationZhang, L., Liu, C., Meng, X., Huang, C., Xu, F., & Li, J. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2258-1 · Cited by 73 · see citing works
Self-citationAmeliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats
Ezhilarasan, D., Karthikeyan, S., & Vivekanandan, P. (2012) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2012.07.004 · Cited by 70 · see citing works
Shu, J.-C., He, Y.-J., Lv, X., Ye, G.-R., & Wang, L. (2009) · Journal of Natural Medicines · doi:10.1007/s11418-009-0347-3 · Cited by 67 · see citing works
Self-citationGuo, C., Li, J., Chen, K., Li, S., Feng, J., Liu, T., Wang, F., Zhang, R., Xu, S., Zhou, Y., et al. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s98740 · Cited by 66 · see citing works
Self-citationGu, Y.-J., Sun, W., Zhang, S., Li, X., & Wei, W. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2692 · Cited by 66 · see citing works
Potent natural products and herbal medicines for treating liver fibrosis
Chen, S., Chen, X., Lu, J., Wang, Y., & Wang, Y. (2015) · Chinese Medicine · doi:10.1186/s13020-015-0036-y · Cited by 64 · see citing works
EZH2‐mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis
Yang, Y., Chen, X., Li, W., Wu, X., Huang, C., Xie, J., Zhao, Y., Meng, X., & Li, J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13153 · Cited by 62 · see citing works
Self-citationZhao, H., Zhang, Z., Chai, X., Li, G.-Q., Cui, H., Wang, H., Meng, Y.-K., Liu, H., Wang, J., Li, R., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.04.040 · Cited by 62 · see citing works
Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target
Zhan, L., Huang, C., Meng, X., Song, Y., Wu, X. Q., Yang, Y., & Li, J. (2014) · Biochimie · doi:10.1016/j.biochi.2014.10.013 · Cited by 61 · see citing works
Self-citationPeng, J., Li, X., Feng, Q., Chen, L., Xu, L., & Hu, Y. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213480741 · Cited by 60 · see citing works
Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis
Chen, X., Li, W., Chen, Y., Li, X., Li, H.-D., Huang, H., Bu, F., Pan, X., Yang, Y., Huang, C., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1032-9 · Cited by 58 · see citing works
Self-citationPeng, X.-D., Dai, L., Huang, C.-Q., He, C., Yang, B., & Chen, L. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.099 · Cited by 58 · see citing works
Morin enhances hepatic Nrf2 expression in a liver fibrosis rat model
Sang, L., Wang, X., Xu, D.-Y., Sang, L.-X., Han, Y., & Jiang, L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8334 · Cited by 55 · see citing works
Wang, H., Wu, G. J., Park, H. J., Jiang, P., Sit, W., van Griensven, L. J., & Wan, J. M. (2012) · Chinese Medicine · doi:10.1186/1749-8546-7-23 · Cited by 53 · see citing works
Zhou, D., Wang, X., Wang, Y., Xiang, X.-J., Liang, Z.-C., Zhou, Y., Xu, A., Bi, C.-H., & Zhang, L. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.05.018 · Cited by 53 · see citing works
miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway
Yang, J., Tao, H., Liu, L., Hu, W. M., Deng, Z.-Y., & Li, J. (2016) · Inflammation Research · doi:10.1007/s00011-016-1020-4 · Cited by 52 · see citing works
Self-citationYuan, L., Chen, F., Lü, L., Hu, B., Chen, Z., Li, F., Zhong, M.-M., & Xia, L.-J. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.10.0016 · Cited by 51 · see citing works
DNMT1 controls LncRNA H19/ERK signal pathway in hepatic stellate cell activation and fibrosis
Yang, J., She, Q., Yang, Y., Tao, H., & Li, J. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.07.013 · Cited by 51 · see citing works
Self-citationLi, J., Liu, P., Zhang, R., Cao, L., Qian, H., Liao, J., Xu, W. R., Wu, M., & Yin, Z.-F. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.030 · Cited by 50 · see citing works
Self-citationLin, X., Kong, L., Huang, C., Ma, T., Meng, X., He, Y., Wang, Q., & Li, J. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.02.009 · Cited by 50 · see citing works
Self-citationXu, T., Ni, M.-M., Xingli, Li, X., Meng, X., Huang, C., & Li, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.010 · Cited by 49 · see citing works
Self-citationHasan, H. F., Abdel-Rafei, M. K., & Galal, S. M. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0142 · Cited by 49 · see citing works
Zhan, L., & Li, J. (2017) · Gene · doi:10.1016/j.gene.2017.10.067 · Cited by 49 · see citing works
Self-citationEvodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway
Yang, D., Li, L., Qian, S., & Liu, L. (2017) · Journal of Natural Medicines · doi:10.1007/s11418-017-1122-5 · Cited by 48 · see citing works
Lack of IL-17 signaling decreases liver fibrosis in murine schistosomiasis japonica
Zhang, Y., Huang, D., Gao, W., Yan, J., Zhou, W., Hou, X., Liu, M., Ren, C., Wang, S., & Shen, J. (2015) · International Immunology · doi:10.1093/intimm/dxv017 · Cited by 47 · see citing works
Tzeng, J., Chen, M., Chung, H., & Cheng, J. (2012) · Phytotherapy Research · doi:10.1002/ptr.4829 · Cited by 47 · see citing works
Wu, Y., Bu, F., Yu, H., Li, W., Huang, C., Meng, X., Zhang, L., Ma, T., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.002 · Cited by 46 · see citing works
Self-citationGeng, Y., Sun, Q., Li, W., Lu, Z., Xu, H., Shi, J., & Xu, Z. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600392 · Cited by 46 · see citing works
Mechanism of collagen resorption in reversible hepatic fibrosis
Hutterer, F., Rubin, E., & Pópper, H. (1964) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(64)90054-1 · Cited by 43 · see citing works
Wan, Y., Wu, Y., Lian, L., Xie, W.-X., Li, X., Ouyang, B.-Q., Bai, T., Li, Q., Yang, N., & Nan, J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.01.002 · Cited by 43 · see citing works
Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis
Li, X., Wu, X., Xu, T., Li, X., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.07.003 · Cited by 43 · see citing works
Self-citationCheng, Y., Tian, Y., Xia, J., Wu, X., Yang, Y., Li, X., Huang, C., Meng, X., Ma, T., & Li, J. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.01.005 · Cited by 43 · see citing works
Self-citationWang, X., & Tian, Z. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0584-x · Cited by 42 · see citing works
Jiang, Y., Wang, C., Li, Y., Wang, X., An, J.-D., Wang, Y., & Wang, X. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.028 · Cited by 41 · see citing works
Chen, P., Huang, C., Meng, X., & Li, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.016 · Cited by 41 · see citing works
Self-citationWu, F., Zheng, H., Yang, Z.-T., Cheng, B., Wu, J., Liu, X.-W., Tang, C., Lu, S., Chen, Z.-N., Song, F., et al. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.03.031 · Cited by 41 · see citing works
Hicks, D. F., Goossens, N., Blas‐García, A., Tsuchida, T., Wooden, B., Wallace, M. C., Nieto, N., Lade, A. G., Redhead, B., Cederbaum, A. I., et al. (2017) · Scientific Reports · doi:10.1038/srep42563 · Cited by 40 · see citing works
Wang, L., Yue, Z. D., Guo, M., Fang, L., Bai, L., Li, X., Tao, Y., Wang, S., Liu, Q., Zhi, D., et al. (2016) · BioMed Research International · doi:10.1155/2016/1068528 · Cited by 40 · see citing works
Yang, J., Lu, Y., Yang, P., Chen, Q., Wang, Y., Ding, Q., Xu, T., Li, X., Li, C., Huang, C., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27521 · Cited by 40 · see citing works
Self-citationWu, X., Wang, Y., Wang, S., Xu, R., & Lv, X. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2016.12.017 · Cited by 39 · see citing works
Self-citationZhang, K., Gao, Y., Zhong, M., Xu, Y., Li, J., Chen, Y., Duan, X., & Zhu, H. L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.053 · Cited by 39 · see citing works
Self-citationCucurbitacin‐B attenuates CC l4‐induced hepatic fibrosis in mice through inhibition of STAT ‐3
Sallam, A.-A. M., Esmat, A., & Abdel‐Naim, A. B. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13160 · Cited by 38 · see citing works
Wogonoside Shows Antifibrotic Effects in an Experimental Regression Model of Hepatic Fibrosis
Wang, Q., Wen, R., Lin, Q., Wang, N., Lü, P., & Zhu, X. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3751-4 · Cited by 38 · see citing works
Kong, R., Wang, N., Luo, H. L., & Lü, J. (2018) · Current Molecular Medicine · doi:10.2174/1566524018666180608084947 · Cited by 37 · see citing works
Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL
Xu, F., Zhou, D., Meng, X., Wang, X., Liu, C., Huang, C., Li, J., & Zhang, L. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.013 · Cited by 36 · see citing works
Self-citationWang, Y.-H., Sun, Y., Zuo, L., Wang, Y., & Huang, Y. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.10.003 · Cited by 36 · see citing works
Li, J., Li, ., Li, S., He, B., Mi, Y., Cao, H., Zhang, C., & Li, L. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.019 · Cited by 36 · see citing works
Self-citationBerberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells
Wang, N., Xu, Q., Tan, H. Y., Hong, M., Li, S., Yuen, M., & Feng, Y. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/8762345 · Cited by 36 · see citing works
DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis
Pan, X., Yang, Y., Meng, H., Li, H.-D., Chen, X., Huang, H., Bu, F., Yu, H., Wang, Q., Huang, C., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00553 · Cited by 36 · see citing works
Self-citationDong, S., Cai, F., Chen, Q., Song, Y., Sun, Y., Wei, B., Li, X., Hu, Y., Liu, P., & Su, S.-B. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.150 · Cited by 35 · see citing works
Wang, Y., Hong, R.-T., Xie, Y., & Xu, J.-M. (2018) · Current Medical Science · doi:10.1007/s11596-018-1871-8 · Cited by 35 · see citing works
Fighting Liver Fibrosis with Naturally Occurring Antioxidants
Lin, L., Zhou, F., Shen, S., & Zhang, T. (2018) · Planta Medica · doi:10.1055/a-0757-0008 · Cited by 34 · see citing works
Exosomal miRNAs as Biomarkers in the Diagnosis of Liver Disease
Wang, S., Wang, J., & Lv, X. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0011 · Cited by 33 · see citing works
Self-citationRole of NLRC5 in progression and reversal of hepatic fibrosis
Liu, X., Wu, Y., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.012 · Cited by 32 · see citing works
Self-citationLi, W., Chen, X., Yang, Y., Huang, H., Li, H.-D., Huang, C., Meng, X., & Li, J. (2016) · Toxicology · doi:10.1016/j.tox.2016.11.004 · Cited by 32 · see citing works
Self-citationHuang, C., Ma, T., Meng, X., Lv, X., Zhang, L., Wang, J., & Li, J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.02.0010 · Cited by 31 · see citing works
Self-citationHu, Z., Qin, F., Gao, S., Zhen, Y., Huang, D., & Dong, L. (2018) · PubMed Central · Cited by 31 · see citing works
Yang, Y., Yang, F., Wu, X., Lv, X., & Li, J. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0437 · Cited by 30 · see citing works
Self-citationYu, J.-L., Li, J., Chengz, R.-G., Ma, Y., Wang, X., & Liu, J. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60062-6 · Cited by 30 · see citing works
Self-citationZhang, C., Liu, X., Sun, H., Meng, X., Bao, Y., Zhang, H.-P., Pan, F., & Zhang, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.08.005 · Cited by 28 · see citing works
Anti-Fibrotic Effects of Neferine on Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice
Chen, M.-S., Zhang, J.-H., Wang, J., Gao, L., Chen, X., & Xiao, J. (2015) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x15500159 · Cited by 28 · see citing works
Guo, Y., Liang, X., Meng, M., Chen, H., Wei, X., Li, M., Li, J., Huang, R., & Wei, J. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.07.005 · Cited by 28 · see citing works
Self-citationLu, C., Xu, W., Zhang, F., Shao, J., & Zheng, S. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.018 · Cited by 27 · see citing works
Effects of tea polyphenols on hepatic fibrosis in rats with alcoholic liver disease.
Li, Y., Zhang, X., Zhou, H., Chen, S., Zhang, Y., & Yu, C. (2004) · PubMed · Cited by 26 · see citing works
Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells
Ni, M.-M., Xu, T., Wang, Y.-R., He, Y.-H., Zhou, Q. Y., Huang, C., Meng, X., & Li, J. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0452-6 · Cited by 26 · see citing works
Self-citationPTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells
Chen, P., Cai, S.-P., Yang, Y., Li, W., Huang, C., Meng, X., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.12.021 · Cited by 26 · see citing works
Self-citationKubo, N., Saito, R., Hamano, K., Nagasawa, M., Aoki, F., Takei, I., Umezawa, K., Kuwano, H., & Kojima, I. (2013) · Liver International · doi:10.1111/liv.12328 · Cited by 25 · see citing works
Deng, T., Liu, J., Zhang, M., Wang, Y., Zhu, G., & Wang, J. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0474 · Cited by 24 · see citing works
Qiao, H., Tong, Y., Han, H., Xu, W., Ren, Z., Ouyang, J., & Chen, Y. (2011) · Die Pharmazie · doi:10.31083/ph.2011.9840 · Cited by 24 · see citing works
Wai, K. K., Liang, Y., Zhou, L., Cai, L., Liang, C., Liu, L., Lin, X., Huahui, W., & Lin, J. (2014) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1292 · Cited by 20 · see citing works
β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Pathway in Alcoholic Liver Disease
Sun, Y.-Y., Zhao, Y., Li, X., Huang, C., Meng, X., & Li, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01031 · Cited by 20 · see citing works
Self-citationChen, Y.-H. (2015) · The Chinese Journal of Physiology · doi:10.4077/cjp.2015.bad285 · Cited by 18 · see citing works
Jiang, H., Qin, X., Li, W., Ma, R., Wang, T., & Li, Z.-Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7078 · Cited by 17 · see citing works
TIPE2 attenuates liver fibrosis by reversing the activated hepatic stellate cells
Xu, D., Li, X., Li, Y., Liu, Y., Huang, C., Meng, X., & Li, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.178 · Cited by 14 · see citing works
Self-citationLiu, L., Jin, M., Tao, Q., Yu, L., Du, J., Wang, C., Luo, Q., Tian, X., Xu, Y., Shen, J., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01572 · Cited by 12 · see citing works
Zhang, X., Zhang, J., Jia, L., & Xiao, S. (2016) · PubMed · Cited by 10 · see citing works
Lin, Y.-C., Luo, H., Wang, X., Zheng, M., Jin, Q., Chen, H., Pan, P.-L., & Zhang, J. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/3080837 · Cited by 9 · see citing works
Tang, X., Hu, W., Lv, Y.-C., Zhang, W., Sun, T., Jiang, Y., Zhan, X., & Zhou, S. (2018) · Medical Science Monitor · doi:10.12659/msm.909320 · Cited by 9 · see citing works
[Effects of Hemerocallis citrine baroni flavonids on CCl4-induced liver fibrosis of rats].
Shen, N., Huang, X.-D., Li, Z., Wang, Y., Qi, L., An, Y., & Liu, T. (2015) · PubMed · Cited by 6 · see citing works
Telomere, telomerase and liver disease
Aravinthan, A. D., & Alexander, G. (2017) · Liver International · doi:10.1111/liv.13630 · Cited by 5 · see citing works
Li, X., He, C., Wu, W., Huang, H., Li, W., & Yin, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2604 · Cited by 4 · see citing works
Wang, Y. L., Lv, H. Y., & Zhang, Q. (2015) · Genetics and Molecular Research · doi:10.4238/2015.september.21.9 · Cited by 3 · see citing works
Flagged first, then by citations
3 of the 115 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Wu, H., Chen, G., Wang, J., Deng, M., Yuan, F., & Gong, J. (2019) · Cell Proliferation · doi:10.1111/cpr.12731 · Cited by 89 · see citing works
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Wang, F.-D., Zhou, J., & Chen, E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.787748 · Cited by 74 · see citing works
Zhang, Q., Luo, P., Zheng, L., Chen, J., Zhang, J., Tang, H., Liu, D., He, X., Shi, Q., Gu, L., et al. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.06.001 · Cited by 56 · see citing works
Self-citationZhou, L., Liang, Q., Li, Y., Cao, Y., Li, J., Yang, J., Liu, J., Bi, J., & Liu, Y. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.065 · Cited by 51 · see citing works
Self-citationWang, H., Ma, J.-X., Zhou, M., Si, J., & Cui, B. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.965934 · Cited by 49 · see citing works
Zheng, Y., Zhao, T., Wang, J., Jiang, R., Huang, J., Li, W., & Wang, J. (2022) · The FASEB Journal · doi:10.1096/fj.202200933rr · Cited by 49 · see citing works
Ma, X., Jiang, Y., Wen, J., Zhao, Y., Zeng, J., & Guo, Y. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173578 · Cited by 41 · see citing works
Shao, M., Wang, Y., Dong, H., Wang, L., Zhang, X., Han, X., Sang, X., Bao, Y., Peng, M., & Cao, G. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.11.001 · Cited by 40 · see citing works
Duan, B., Liu, Y., Li, X., Han, M., Yu, H., Hong, H., Zhang, L., Xing, L., & Jiang, H. (2024) · Advanced Science · doi:10.1002/advs.202306899 · Cited by 38 · see citing works
Yin, K., Li, X., Luo, X., Sha, Y.-R., Gong, P., Gu, J. P., & Tan, R. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5345821 · Cited by 38 · see citing works
Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4‐Dependent ROS
Zhou, M., Zhao, X., Liao, L., Deng, Y., Liu, M., Wang, J., Xue, X., & Li, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9938392 · Cited by 35 · see citing works
USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
Zhao, J., Bai, J., Peng, F., Qiu, C., Li, Y., & Zhong, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-022-05527-9 · Cited by 33 · see citing works
Jia, W., Liang, S., Cheng, B., & Ling, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.763519 · Cited by 33 · see citing works
Natural Products for Liver Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
Kim, D. B., Lee, D. K., Cheon, C., Ribeiro, R. I. M. D. A., & Kim, B. (2022) · Nutrients · doi:10.3390/nu14204252 · Cited by 31 · see citing works
Ma, Z., Sheng, L., Li, J., Qian, J., Wu, G., Wang, Z., & Zhang, Y. (2022) · Inflammation · doi:10.1007/s10753-021-01586-w · Cited by 29 · see citing works
Self-citationLi, W., Liu, W., Qian, D., Liu, J., Zhou, S.-Q., Zhang, L., Peng, W., Su, L., & Zhang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.962525 · Cited by 29 · see citing works
Liu, F., Sun, C., Chen, Y., Du, F., Yang, Y., & Wu, G. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00032 · Cited by 28 · see citing works
LPS-TLR4/MD-2–TNF-α signaling mediates alcohol-induced liver fibrosis in rats
Mou, W., Chen, S.-R., Wu, Z., Hu, L., Zhang, J.-Y., Chang, H.-J., Zhou, H., & Liu, Y. (2022) · Journal of Toxicologic Pathology · doi:10.1293/tox.2021-0018 · Cited by 28 · see citing works
Hu, J., Liu, Y., Pan, Z., Huang, X., Wang, J., Cao, W., & Chen, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065933 · Cited by 29 · see citing works
Jiang, J., Wang, F., Luo, A., Lin, S., Feng, X., Yan, W., Shi, Y., Zhang, Q., Gu, X., Cui, G., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00767 · Cited by 27 · see citing works
Huang, J., Li, Y., Xu, D., Zhang, X., & Zhou, X. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174137 · Cited by 26 · see citing works
Artificial Intelligence in Liver Diseases: Recent Advances
Lu, F., Meng, Y., Song, X., Li, X., Liu, Z., Gu, C., Zheng, X., Yi, J., Cai, W., Pinyopornpanish, K., et al. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02781-5 · Cited by 25 · see citing works
Self-citationProanthocyanidins attenuated liver damage and suppressed fibrosis in CCl4-treated rats
Amer, M. A., Othman, A. I., El-Missiry, M. A., Farag, A. A., & Amer, M. E. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22051-7 · Cited by 25 · see citing works
Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
Nan, Y., Su, H., Lian, X.-M., Wu, J., Liu, S., Chen, P., & Liu, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5325431 · Cited by 24 · see citing works
Melaibari, M., Alkreathy, H. M., Esmat, A., Rajeh, N. A., Shaik, R. A., Alghamdi, A. A., & Ahmad, A. (2023) · Biomedicines · doi:10.3390/biomedicines11051342 · Cited by 24 · see citing works
Role of Nrf2 and HO-1 in intervertebral disc degeneration
Zhang, C., Hu, X., Zhang, G., Liu, M.-Q., Chen, H., & Kang, X. (2022) · Connective Tissue Research · doi:10.1080/03008207.2022.2089565 · Cited by 23 · see citing works
Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects
Ye, X., Li, J., Liu, Z., Sun, X., Wei, D., Song, L., & Wu, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113978 · Cited by 23 · see citing works
Self-citationNatural products target glycolysis in liver disease
Li, S., Hao, L., & Hu, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1242955 · Cited by 22 · see citing works
Ding, W., Yang, X., Lai, K., Jiang, Y., & Liu, Y. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01490-5 · Cited by 21 · see citing works
Shen, C., Huang, X., Geng, C., Li, T.-Z., Tang, S., Su, L., Gao, Z., Zhang, X., Jing Hua, H. U., & Chen, J. (2020) · Natural Products and Bioprospecting · doi:10.1007/s13659-020-00254-0 · Cited by 20 · see citing works
Ma, Y., Du, X., Zhao, D., Tang, K., Wang, X., Guo, S., Li, X., Mei, S., Sun, N., Liu, J., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.059 · Cited by 20 · see citing works
Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease
Li, Y., Yunrui, L. U., Mozuo, N. I. A. N., Sheng, Q., ZHANG, C., Han, C. Q., Dou, X., & Ding, Y. (2023) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(23)60443-1 · Cited by 20 · see citing works
Wang, Z., Guo, S., Cai, Y., Yang, Q., Wang, Y., Yu, X., Sun, W., Qiu, S., Li, X., Guo, Y. L., et al. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.107090 · Cited by 20 · see citing works
Jiang, G., Kong, H., Wang, Y., Wang, Y., Zhou, J., Wang, Z., & Niu, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140234 · Cited by 19 · see citing works
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
Gao, S., Jiang, X., Wang, L., Jiang, S., Luo, H., Chen, Y., & Peng, C. Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1029601 · Cited by 18 · see citing works
Huang, H., Wei, S., Wu, X., Zhang, M., Zhou, B., Huang, D., & Dong, W. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116438 · Cited by 18 · see citing works
Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites
He, X.-Y., Liang, J., Li, X., Wang, Y., Zhang, X., Chen, D., Wu, L., & Wang, S. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117402 · Cited by 18 · see citing works
Chen, H., Zhang, G., Liu, M.-Q., Zhang, L., Kang, J., Wang, Z., Liu, W., Lin, A., & Kang, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9963677 · Cited by 18 · see citing works
Wang, H., Chang, Y., Liu, X., Liu, L., Hua, M., & Li, A. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14386 · Cited by 16 · see citing works
Dong, Z., Guan, H., Wang, L., Liang, L., Zang, Y., Wu, L., & Bao, L. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13314 · Cited by 16 · see citing works
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis
Liu, C., Li, S., Zhang, C., & Jin, C. H. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230727102016 · Cited by 15 · see citing works
Zhang, L., Wang, Q., Gao, N., Lin, G., Hu, D., Liu, J., Wang, J., Zhao, S., Zhang, J., Zheng, T., et al. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104640 · Cited by 15 · see citing works
Self-citationApigenin intervenes in liver fibrosis by regulating PKM2-HIF-1α mediated oxidative stress
Sun, T., Li, S., Lei, Y., Lei, Y., Wang, B., Liu, X., Yu, S., & Li, N. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150130 · Cited by 14 · see citing works
Li, T., Fu, W., Li, X., Huo, Y., Ji, H., Liang, T., & Zhang, R. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c15494 · Cited by 14 · see citing works
Yan, J., Feng, Y., Fang, X., Cui, X., Xia, X., Li, F., Luo, W., Liang, J., Feng, J., & Yu, K. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2086584 · Cited by 13 · see citing works
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Harini, K. S., & Ezhilarasan, D. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105467 · Cited by 13 · see citing works
Wu, X., Guan, Y., Wang, J., Song, L., Zhang, Y., Wang, Y., Li, Y., Qin, L., He, Q., Zhang, T., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155340 · Cited by 13 · see citing works
Chen, J., Liu, H., Fu, Y., Chen, X., Zhang, S., Yang, Y., Li, S., Wang, G., & Lan, T. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103533 · Cited by 14 · see citing works
Protective Effects of Phytic Acid on CCl4-Induced Liver Fibrosis in Mice
Xu, Z., Zhao, C., Lan, T., Han, Y., Yang, N., Wang, C., Tao, M., Li, H., Song, Y., & Ma, X. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/6634450 · Cited by 12 · see citing works
Zhang, S., Tang, F., Zhou, Z., Li, L., Tang, Y., Fu, K., Tan, Y., & Li, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146666 · Cited by 11 · see citing works
Zhu, Z.-F., Wang, S., Liu, X.-F., Liu, N., Dong, D., Qi, Y.-C., Li, N., Wang, N., Tan, J., Jia, C., et al. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.124661 · Cited by 10 · see citing works
Buakaew, W., Krobthong, S., Yingchutrakul, Y., Khamto, N., Sutana, P., Potup, P., Thongsri, Y., Daowtak, K., Ferrante, A., Léon, C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168995 · Cited by 11 · see citing works
LRP6-CRISPR prevents activation of hepatic stellate cells and liver fibrogenesis in rats.
Yu, L., Wang, L., Yi, H., & Wu, X. (2020) · PubMed Central · Cited by 11 · see citing works
The effects of taraxasterol on liver fibrosis revealed by RNA sequencing
He, H., Xu, B., Ge, P., Gao, Y., Wei, M., Li, T., Zhang, R., Li, B., Cao, H., & Zhang, K. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109481 · Cited by 10 · see citing works
Xu, A., Han, L., Yan, J., Liu, D., & Wang, W. (2024) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-024-00631-7 · Cited by 11 · see citing works
Su, X., Zhong, H., Zeng, Y., Zhang, Y., Zhang, B., Guo, W., Huang, Q., & Ye, Y. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114376 · Cited by 10 · see citing works
Hong, B., Wang, Y., Hou, Y., Liu, R., & Li, W. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123416 · Cited by 10 · see citing works
Qu, R., Zhang, W., Ma, Z., Ma, Q., Chen, M., Lan, T., Zhou, L. M., & Hu, X. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14241 · Cited by 10 · see citing works
Luo, R., Fang, C., Chen, C., Zhang, Y., Yao, R., Wang, J., Shi, H., Feng, K.-L., Hu, M., & Zhong, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1212116 · Cited by 10 · see citing works
He, X.-Y., Xiong, X.-J., Liu, M., Liang, J., Liu, F., Xiao, J.-Y., & Wu, L. (2024) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-024-3801-x · Cited by 9 · see citing works
Gong, P., Yin, K., Luo, X., Gu, J., Tan, R., Wu, Y., & Li, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989995 · Cited by 9 · see citing works
Cell-based 3D bionic screening by mimicking the drug–receptor interaction environment in vivo
Wei, F., Zhang, X., Cui, P., Gou, X., & Wang, S. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb02661a · Cited by 9 · see citing works
Liu, D., Yang, K., Li, T., Tang, T., Wang, Y., Wang, W., Li, J., Zhou, P., Wang, X., Zhao, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34214 · Cited by 8 · see citing works
Self-citationKong, D., Xu, J., Zhang, Q., Luo, D., Lv, Q., Li, S., Chen, X., Wei, L., Zhu, X., Liu, Y., et al. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c09084 · Cited by 8 · see citing works
Zhu, X., Zhong, Z., Du, J., Zhang, J., Zhang, X., Cui, X., Guan, L., Hu, Y., Chen, C., Wang, H., et al. (2025) · Liver International · doi:10.1111/liv.70187 · Cited by 8 · see citing works
Wang, W., Zhang, Y., Jiang, Y., Wang, Y., Zhu, J., Wang, C., Han, X., & Wang, J. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115960 · Cited by 8 · see citing works
Xue, Y., Zhu, W., Qiao, F., Yang, Y., Qiu, J., Zou, C., Gao, Y., Zhang, X., Li, M., Shang, Z., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118169 · Cited by 8 · see citing works
Ye, Z., Huang, Q., She, Y., Hu, Y., Wu, M., Qin, K., Li, L., Zhang, C., Zuo, X., Wei, A., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.920062 · Cited by 7 · see citing works
Jin, F.-C., Chen, J., Xu, Q.-X., Zhou, M.-H., Lin, Y., Zhang, Q.-W., Zhang, C., & Zhang, Z. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116655 · Cited by 7 · see citing works
Yu, S., Pu, J., Liu, K., He, C., Yang, F., Chen, K., Yang, X., Zhu, Y., Jiang, J., Luo, M., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1636538 · Cited by 6 · see citing works
Hydrolysable tannins as a potential therapeutic drug for the human fibrosis‐associated disease
Wang, M., & Cao, L. (2023) · Drug development research (Print) · doi:10.1002/ddr.22089 · Cited by 7 · see citing works
Wang, D., Wang, X., Gu, X., Zhang, Y. X., Jiang, Y., Liu, Y., & Di, X. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117556 · Cited by 6 · see citing works
Zhao, T., Yu, M., Zhang, L., Liu, W., Huang, Q., Huang, L., Zhang, Y., & Nan, H. (2024) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2023.100949 · Cited by 5 · see citing works
Carballo-López, G. I., Ojeda-González, J., Martínez-García, K. D., Cervantes-Luévano, K., Moreno‐Ulloa, A., & Castro-Ceseña, A. B. (2024) · Molecular Omics · doi:10.1039/d4mo00195h · Cited by 5 · see citing works
Xue, W., Liu, H., Su, Z., Wang, S., Cheng, J., Pan, Y., & Zhang, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1525914 · Cited by 5 · see citing works
Li, W., Lv, R., Zou, T., & Chen, M. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122798 · Cited by 5 · see citing works
The Novel Effect and Potential Mechanism of Lactoferrin on Organ Fibrosis Prevention
Yu, Y., Fang, J., Li, Y., Wang, X., Zhang, J., Wang, J., & Sun, B. (2025) · Nutrients · doi:10.3390/nu17010197 · Cited by 4 · see citing works
El‐Fakharany, E. M., El-Sayed, M. H., Ali, H. M., Omar, S. M., Sayed, A. M., Atwa, A. M., Alfaifi, M. Y., Shati, A. A., Elbehairi, S. E. I., Alrayes, Z. R., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-03100-w · Cited by 4 · see citing works
Liu, Z., Jiang, X., You, H., Tang, Z., Ma, Y., Che, N., Liu, W., & Ma, C. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05152-4 · Cited by 4 · see citing works
Self-citationLiang, L., Dong, Z., Shen, Z., Zang, Y., Yang, W., Wu, L., & Bao, L. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13536 · Cited by 4 · see citing works
The gut microbe Bacteroides acidifaciens ameliorates CCl4-induced liver fibrosis
Ye, F., Hou, Y., Huang, M., Guo, Y., Ye, Y., Liu, Y., Zou, L., Bao, Y., Yuan, R., Zhu, F., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178265 · Cited by 4 · see citing works
Cheng, J., Chen, Z., Zuo, G., & Cao, W. (2022) · Journal of International Medical Research · doi:10.1177/03000605221074525 · Cited by 4 · see citing works
Effects of salvianolic acid B on liver fibrosis
Ma, X., Tang, M., Lu, L., Zheng, J., Huang, J., Li, J., & Luo, W. (2020) · Medicine · doi:10.1097/md.0000000000021036 · Cited by 4 · see citing works
Self-citationRole of miRNA signalling in the pathogenesis of MASLD
Cheng, S.-L., Hao, J.-S., & Qin, H.-Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1756805 · Cited by 3 · see citing works
Xiao, X., Yang, F., Huang, Y., Liu, S., Hu, Z., Liao, S., & Li, Y. (2024) · Antioxidants · doi:10.3390/antiox13080907 · Cited by 3 · see citing works
Huang, L., Xu, Y., Lai, Z., Zhou, Z., & Deng, M. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100227 · Cited by 3 · see citing works
Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules
Lv, C., Li, Y., Ou, L., Zhou, J., Peng, F., & Wu, D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1122118 · Cited by 3 · see citing works
Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism
Frión-Herrera, Y., Zanotto, I., Colognesi, M., Signor, A., Cuffaro, D., Chilin, A., Macchia, M., Marzaro, G., Digiacomo, M., Gabbia, D., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177847 · Cited by 3 · see citing works
Research progress of natural products interfering with cell signaling pathway in liver fibrosis
Qin, L.-J., Zhang, L., Zheng, Z., & Zhong, X.-H. (2021) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2021.1883003 · Cited by 2 · see citing works
Wen, J., Xiang, Q., Chen, Y., Hu, T., Ma, X., Huang, Y., & Rao, C. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110565 · Cited by 2 · see citing works
Guo, Y.-F., Ying, L., Zhang, H., Wang, M.-Y., Yang, D., & Liu, W. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121988 · Cited by 2 · see citing works
Zhao, J., Tian, X., Zhang, J., Huang, C., Sun, Y., Qiao, S., & Jiang, S. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3706-0 · Cited by 2 · see citing works
Bioactive alkaloids from the venom of Dendrobatoidea Cope, 1865: a scoping review
Arraes, D. R. D. S., Rodrigues, A. B. L., Sanches, P. R., Costa-Campos, C. E., de Almeida, S. S. M. D. S., Lima, J. R. F., Lima, J. D., & Araújo‐Silva, G. (2023) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2023.2270408 · Cited by 2 · see citing works
Tang, A., Wei, L., Gao, J., Zhang, Z., Xia, B., Li, X., & Lu, Q. (2025) · Drug and Chemical Toxicology · doi:10.1080/01480545.2025.2527178 · Cited by 1 · see citing works
Erianin ameliorates liver fibrosis through the PRDX3/NLRX1 axis
Zhu, M., Yang, X., Xie, J., Shi, X., Li, J., Shi, Y., Zhang, L., Tian, X., Li, Y., Yao, J., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179110 · Cited by 1 · see citing works
Self-citationLOC102553417 silencing facilitates the apoptosis of hepatic stellate cells via the miR‑30e/MTDH axis
Wei, W., Lin, C., Hu, R., Huang, J., Chen, X., Zhou, L., Wei, J., Deng, Y., & Wang, C. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12865 · Cited by 1 · see citing works
Jiang, T., Chen, X., Yang, W., Li, N., Xu, J., Yang, L., Zhang, S., Yu, S., & Li, Y. (2023) · Natural Product Communications · doi:10.1177/1934578x231194127 · Cited by 1 · see citing works
Huang, X., Xu, L., Li, Y., Mingyue, S. O. N. G., & Dongwang, Z. H. A. N. (2023) · Minerva Medica · doi:10.23736/s0026-4806.23.08787-6
Role of Lifestyle Changes and Natural Herbs in the Management of Hepatic Health
Singh, A., Mazumder, A., Das, S., & Kanda, A. (2023) · Journal of Natural Remedies · doi:10.18311/jnr/2023/34070
El-Hameed, D. A. (2023) · Egyptian Journal of Aquatic Biology and Fisheries · doi:10.21608/ejabf.2023.318808
- Authors
- Shan, L., Liu, Z., Ci, L., Shuai, C., Lv, X., & Li, J.
- Affiliations
- Anhui Medical University (CN)
- Corresponding author
- Lv, Xiongwen
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 75
- Pages
- 105765
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W2963885368
- Cited by
- 111
- References
- 115
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 21 · 2023: 25 · 2022: 25 · 2021: 7 · 2020: 6 · 2019: 1
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- International Immunopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81270498)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Complementary and alternative medicine › Traditional Chinese Medicine Analysis
- Health Sciences › Medicine › Pharmacology › Flavonoids in Medical Research
- Keywords
- liver fibrosis, traditional Chinese medicine, flavonoids, saponins, polysaccharides, alkaloids, liver inflammation, lipid peroxidation, hepatic stellate cells, extracellular matrix, liver cirrhosis, drug development
- MeSH terms
- Animals, Biological Products, Humans, Liver Cirrhosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review